Meg Fluharty summarises a recent Cochrane review, which tells us that high-dose buprenorphine is an effective maintenance treatment for heroin compared to placebo, but fixed flexible-dosing methadone is superior to buprenorphine at participant retention.
[read the full story...]
Approximately 10.6% of individuals with Substance Use Disorders (SUD) in the US seek treatment, with 40-60% relapsing within a year (Dept of Health and Human Services, 2008; McLellan et al, 2000). This highlights a real need for substance abuse treatment that focuses on relapse prevention. This blog summarises a recent RCT from JAMA Psychiatry on [read the full story…]
It is well known that tobacco is the leading cause of preventable death in the world (WHO, 2011). However, the associations between smoking and mental health are less well established. Smokers often want to quit, but the belief that cigarettes can be used to regulate mood can often deter them, and this is especially true [read the full story…]
It’s well known that individuals with mental illness smoke nearly twice as much as those without a psychiatric disorder (Gfroerer et al, 2013; Lasser et al, 2000), and are more addicted to nicotine, smoke more cigarettes per day, and find it more difficult to quit (Lasser et al, 2000). However, studies have shown that individuals [read the full story…]
Varenicline is a prescription drug to help people stop smoking that works by stimulating the nicotine receptors in the brain to reduce cravings and decrease the pleasure that results from smoking. Quit attempts aided by varenicline are up to 2-3 times more successful than those without (Cahill et al 2009 and 2012). However, following the [read the full story…]
This month in the woodland (and the Twittersphere) we’ve given you #MindfulnessMonday. It’s been our attempt to highlight some of the potential benefits that mindfulness can have on our mental well-being in a variety of different health conditions including breast cancer, depression and anxiety, and psychosis. This last #MindfulnessMonday blog examines the effectiveness of Mindfulness-Based Stress [read the full story…]
We often hear about postnatal depression, a well-recognised depressive episode in mothers occurring after the birth of their baby. However, 54.2% of women suffering from postnatal depression actually developed their depressive symptoms before or during pregnancy (Burt and Quezada, 2009). Around 10% of pregnant mothers have depression and this number increases each trimester. Women are less likely [read the full story…]
Attention Deficit Hyperactivity Disorder (ADHD) is the most common behavioural disorder in the UK, with sufferers experiencing inattentiveness, hyperactivity, and impulsivity. It is estimated to affect 3-9% of school aged children and young people in the UK (those aged 3 to 18), and 2% of adults worldwide (DSM-IV criteria). Typically ADHD will continue from childhood [read the full story…]
